- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04554342
Testing of a Candy in Five Different Versions for the Additional Humidification of the Oral Cavity (DESERTO)
February 18, 2021 updated by: University Hospital, Basel, Switzerland
Testing of a Candy in Five Different Versions for the Additional Humidification of the Oral Cavity (DESERTO)
This study is to investigate whether a candy can increase moisture of the oral cavity and reduce dryness of mouth.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A candy (available on the market from a Swiss manufacturer (Ricola)), free of ingredients that could interfere with the investigation, is tested in five different versions on different days.
It is to analyse whether these candies can increase moisture of the oral cavity and reduce dryness of mouth.
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basel, Switzerland, 4058
- Universitäres Zentrum für Zahnmedizin Basel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- non- smoker
- no allergies
- no drug- use (except for contraception)
- healthy volunteers (no disease/infection 4 weeks before study participation)
Exclusion Criteria:
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: healthy participants starting with candy V01
healthy participants testing a candy in 5 different variations by (unstimulated and stimulated) salivary flow rate (before and after comparison)
|
candy with sweetener (Isomalt) and apple flavour
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid)
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid) and Vitamin C
candy with sweetener (Isomalt) (control group 1)
candy with with sweetener (Isomalt) and acidifying agent (apple acid + citric acid) (control group 2)
|
Experimental: healthy participants starting with candy V02
|
candy with sweetener (Isomalt) and apple flavour
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid)
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid) and Vitamin C
candy with sweetener (Isomalt) (control group 1)
candy with with sweetener (Isomalt) and acidifying agent (apple acid + citric acid) (control group 2)
|
Experimental: healthy participants starting with candy V03
|
candy with sweetener (Isomalt) and apple flavour
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid)
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid) and Vitamin C
candy with sweetener (Isomalt) (control group 1)
candy with with sweetener (Isomalt) and acidifying agent (apple acid + citric acid) (control group 2)
|
Experimental: healthy participants starting with candy V04
|
candy with sweetener (Isomalt) and apple flavour
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid)
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid) and Vitamin C
candy with sweetener (Isomalt) (control group 1)
candy with with sweetener (Isomalt) and acidifying agent (apple acid + citric acid) (control group 2)
|
Experimental: healthy participants starting with candy V05
|
candy with sweetener (Isomalt) and apple flavour
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid)
candy with with sweetener (Isomalt) and apple flavour and acidifying agent (apple acid + citric acid) and Vitamin C
candy with sweetener (Isomalt) (control group 1)
candy with with sweetener (Isomalt) and acidifying agent (apple acid + citric acid) (control group 2)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dryness of mouth- sensation
Time Frame: one point assessment following consumption of candy (approx 5 minutes)
|
dryness of mouth- sensation by Visual analogue scale (VAS); 0 = does not apply; 10 = is absolutely true.
|
one point assessment following consumption of candy (approx 5 minutes)
|
Change in salivary flow rate (ml/min)
Time Frame: before and after consumption of candy (approx 5 minutes for each salivary flow measurement)
|
Change in salivary flow rate (ml/min) before and after stimulation (mechanical and gustatory) by consumption of candy
|
before and after consumption of candy (approx 5 minutes for each salivary flow measurement)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Andreas Filippi, Prof. Dr. med. dent., Universitäres Zentrum für Zahnmedizin Basel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 28, 2020
Primary Completion (Actual)
February 10, 2021
Study Completion (Actual)
February 18, 2021
Study Registration Dates
First Submitted
September 14, 2020
First Submitted That Met QC Criteria
September 14, 2020
First Posted (Actual)
September 18, 2020
Study Record Updates
Last Update Posted (Actual)
February 21, 2021
Last Update Submitted That Met QC Criteria
February 18, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-01942; ex19Filippi3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerostomia
-
Cathrine RahbekDanish Cancer Society; DLHM - Danish Society for Mouth and Throat Cancer; Danish...Active, not recruitingXerostomia Following Radiotherapy | Xerostomia Following in Neck Ore Head After CancersurgeryDenmark
-
Bedford Hospital NHS TrustUnknownXerostomia | Xerostomia Due to Radiotherapy | Xerostomia Due to Hyposecretion of Salivary Gland
-
Institute of Oncology LjubljanaUniversity Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...Not yet recruitingXerostomia Following RadiotherapySlovenia
-
Catholic University of the Sacred HeartSunstar Italiana SRL.CompletedXerostomia | Xerostomia Following RadiotherapyItaly
-
Qazvin University Of Medical SciencesImam Khomeini HospitalCompletedRadiation-Induced XerostomiaIran, Islamic Republic of
-
Laboratoires CARILENEDERMSCAN-PHARMASCAN GROUP in charge of data analysisCompleted
-
Institut de Terapia Regenerativa TissularUnknownXerostomia Due to RadiotherapySpain
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
Thomas KuhntVerband Deutscher DruckkammerzentrenTerminatedRadiation-induced XerostomiaGermany
Clinical Trials on V01 candy
-
TCI Co., Ltd.CompletedCardiovascular DiseasesChina
-
TCI Co., Ltd.Completed
-
West Coast UniversityCompleted
-
Cancer Institute and Hospital, Chinese Academy...Guangxi Center for Disease Control and PreventionUnknown
-
Institut de Recherches Cliniques de MontrealVertex Pharmaceuticals Incorporated; Université de MontréalCompletedCystic Fibrosis | Cystic Fibrosis-related DiabetesCanada
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPoliomyelitis | PolioChina
-
Mayo ClinicCompleted
-
University of MinnesotaWithdrawnStress Perception | Discretionary Calories | Over All HealthUnited States
-
Queens College, The City University of New YorkCompletedDiabetes | PreDiabetesUnited States